These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3591464)

  • 1. Vasospastic angina: control of disease activity and efficacy of drug treatment using the prolonged hyperventilation test.
    Nielsen H; Mortensen SA; Sandøe E
    Acta Med Scand; 1987; 221(3):261-5. PubMed ID: 3591464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergonovine provocation to assess efficacy of long-term therapy with calcium antagonists in Prinzmetal's variant angina.
    Winniford MD; Johnson SM; Mauritson DR; Hillis LD
    Am J Cardiol; 1983 Mar; 51(5):684-8. PubMed ID: 6338688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value and limitations of provocative testing to assess the efficacy of treatment in variant angina.
    Waters DD
    Cardiovasc Clin; 1983; 14(1):87-98. PubMed ID: 6352031
    [No Abstract]   [Full Text] [Related]  

  • 4. Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs.
    Waters DD; Szlachcic J; Theroux P; Dauwe F; Mizgala HF
    Am J Cardiol; 1981 Jan; 47(1):179-84. PubMed ID: 6779619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness and limitations of the ergonovine maleate test in the evaluation of calcium-antagonist therapy in Prinzmetal variant angina].
    Previtali M; Salerno JA; Panciroli C; Moizi M; Chimienti M; Montemartini C; Bobba P
    G Ital Cardiol; 1986 Oct; 16(10):863-71. PubMed ID: 3817369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Must the medical treatment of vasospastic angina be continued indefinitely?].
    Waters DD; Chaitman BR; Szlachcic J; Théroux P
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():161-8. PubMed ID: 6407439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous remission of variant angina documented by Holter monitoring and ergonovine testing in patients treated with calcium antagonists.
    Previtali M; Panciroli C; Ardissino D; Chimienti M; Angoli L; Salerno JA
    Am J Cardiol; 1987 Feb; 59(4):235-40. PubMed ID: 3812271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-pharmacological provocation of coronary vasospasm. Experience with prolonged hyperventilation in the coronary care unit.
    Mortensen SA; Vilhelmsen R; Sandøe E
    Eur Heart J; 1983 Jun; 4(6):391-7. PubMed ID: 6617685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-channel blockers in vasospastic angina--a review.
    Ambrosio G
    Postgrad Med J; 1983; 59 Suppl 3():26-9. PubMed ID: 6359108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vasospastic angina].
    Mereuţa A
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):791-6. PubMed ID: 17438877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina.
    Girotti LA; Crosatto JR; Messuti H; Kaski JC; Dyszel E; Rivas CA; Araujo LI; Vetulli HD; Rosenbaum MB
    Am J Cardiol; 1982 Mar; 49(4):834-41. PubMed ID: 7064832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperventilation test: a noninvasive screening test for coronary vasospasm].
    Mang G; Schuiki E; Amann FW
    Schweiz Med Wochenschr; 1995 Apr; 125(16):777-85. PubMed ID: 7732351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Objective evaluation of calcium antagonists in Prinzmetal's angina with the ergonovine test].
    Waters DD; Szlachcic J; Lette J; Théroux P
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():33-40. PubMed ID: 6407448
    [No Abstract]   [Full Text] [Related]  

  • 15. New directions in the use of calcium channel blockers.
    Willerson JT
    Am J Med; 1985 Feb; 78(2B):1-5. PubMed ID: 3976690
    [No Abstract]   [Full Text] [Related]  

  • 16. Angina-linked syncope and lack of calcium antagonist therapy predict cardiac arrest before definitive diagnosis of vasospastic angina.
    Igarashi Y; Tamura Y; Tanabe Y; Fujita T; Yamazoe M; Shibata A
    Coron Artery Dis; 1994 Nov; 5(11):881-7. PubMed ID: 7719520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina.
    Waters DD; Théroux P; Szlachcic J; Dauwe F
    Am J Cardiol; 1981 Jul; 48(1):123-30. PubMed ID: 7246434
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperventilation-echocardiography test for the diagnosis of myocardial ischaemia at rest.
    Morales MA; Reisenhofer B; Rovai D; Moscarelli E; Distante A; L'Abbate A
    Eur Heart J; 1993 Aug; 14(8):1088-93. PubMed ID: 8404939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis.
    Lim AY; Park TK; Cho SW; Oh MS; Lee da H; Seong CS; Gwag HB; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Ahn J; Carriere KC; Choi SH
    Int J Cardiol; 2016 Oct; 221():161-6. PubMed ID: 27400315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
    Io K; Minatoguchi S; Nishigaki K; Ojio S; Tanaka T; Segawa T; Matsuo H; Watanabe S; Hattori A; Ueno K; Ono H; Hiei K; Sato H; Morita N; Noda T; Kato T; Kawasaki M; Takemura G; Fujiwara H
    Arzneimittelforschung; 2007; 57(9):573-81. PubMed ID: 17966756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.